Your Location:
Home >
Browse articles >
Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis: A Review
Updated:2026-04-01
    • Chinese Medicine Regulates Nrf2 Signaling Pathway for Treating Hepatic Fibrosis: A Review

      Enhanced Publication
    • QIU Shuxuan , GUO Lin , WANG Ruiying , MA Xudong , MIAO Mingsan
    • Chinese Journal of Experimental Traditional Medical Formulae Vol. 32, Issue 9, Pages: 276-283(2026)
    • DOI: 10.13422/j.cnki.syfjx.20251241     

      CLC:
    • Revised:2025-06-05

      Accepted:11 June 2025

    Scan QR Code

  •  
  •  
  • AI Introduction

  • Full Text(HTML)

  • Figs( 1 ) Tabs( 0 )

  • References

  • Publication Info

  • Metrics

174

Views

81

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
  • BibTeXDownload
  • EndnoteDownload
  • RefMan Download
  • NoteExpressDownload
  • NoteFirstDownload

Related Articles

Mechanism of Diaphragmatic Dysfunction in Chronic Obstructive Pulmonary Disease and Treatment with Traditional Chinese Medicine: A Review
Traditional Chinese Medicine Treats Hepatic Fibrosis via NF-κB Signaling Pathway: A Review
Traditional Chinese Medicine Against Liver Fibrosis Based on Autophagy: A Review
Effect and Mechanism of Modified Sini San on Improving Intestinal Mucosal Barrier of Chronic Stress Rats via Regulating Short-chain Fatty Acid Metabolism and Inhibiting HMGB1/RAGE Signaling Pathway
Tangbikang Granules Improve Diabetic Peripheral Neuropathy by Inhibiting Ferroptosis via AMPK/Nrf2 Signaling Pathway

Related Author

YING Yuanyuan
ZHOU Xiaoqing
NI Kaiwen
WANG Zhen
LI Zishun
ZHAO Changpu
CHEN Renwu
LI Meiling

Related Institution

The First Affiliated Hospital of Zhejiang Chinese Medical University/ Zhejiang Provincial Hospital of Chinese Medicine
The First Clinical Medical School of Zhejiang Chinese Medical University
The Second Clinical Medical School of Henan University of Chinese Medicine
Henan Provincial Hospital of Traditional Chinese Medicine
Gansu University of Chinese Medicine